Glasson Y, Chépeaux L-A, Dumé A-S, Lafont V, Faget J, Bonnefoy N, Michaud H-A Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology. Semin Immunopathol. 2023;45(1):17-28. doi:10.1007/s00281-022-00978-w
Ursino C, Mouric C, Gros L, Bonnefoy N, Faget J Intrinsic features of the cancer cell as drivers of immune checkpoint blockade response and refractoriness. Front Immunol. 2023;14. doi:10.3389/fimmu.2023.1170321
Robert M, Chépeaux L-A, Dumé A-S, Sannier A, Papo T, Bonnefoy N, Michaud H-A, Sacré K Comprehensive analysis of cell lineages involved in giant cell arteritis pathogenesis using highly multiplexed imaging mass cytometry. Autoimmun Rev. 2023;22(1):103216. doi:10.1016/j.autrev.2022.103216
Massol O, Ramos J, Mollevi C, Lopez-Crapez E, Bonnefoy N, Boissière-Michot F, Jacot W Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer. Cancers (Basel). 2022;14(19):4829. doi:10.3390/cancers14194829
Pinjusic K, Dubey O, Egorova O, Nassiri S, Meylan E, Faget J, Constam D Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. J Immunother Cancer. 2022;10(5):e004533. doi:10.1136/jitc-2022-004533
Glasson Y, Chépeaux L-A, Dumé A-S, Jay P, Pirot N, Bonnefoy N, Michaud H-A A 31-plex panel for high-dimensional single-cell analysis of murine preclinical models of solid tumors by imaging mass cytometry. Front Immunol. 2022;13. doi:10.3389/fimmu.2022.1011617
Faget J, Peters S, Quantin X, Meylan E, Bonnefoy N Neutrophils in the era of immune checkpoint blockade. J Immunother Cancer. 2021;9(7):e002242. doi:10.1136/jitc-2020-002242
Lafont V, Lucas S, Bonnefoy N Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.691899
Boissière-Michot F, Chabab G, Mollevi C, Guiu S, Lopez-Crapez E, Ramos J, Bonnefoy N, Lafont V, Jacot W Clinicopathological Correlates of ?? T Cell Infiltration in Triple-Negative Breast Cancer. Cancers (Basel). 2021;13(4):765. doi:10.3390/cancers13040765
Gros L, Paturel C, Perrot I, Bensussan A, Eliaou J-F, Bastid J, Bonnefoy N [A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response]. Med Sci (Paris). 2020;36(2):112-115. doi:10.1051/medsci/2020006
Pichard A, Marcatili S, Karam J, Constanzo J, Ladjohounlou R, Courteau A, Jarlier M, Bonnefoy N, Patzke S, Stenberg V, Coopman P, Cartron G, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, Dahle J, Bardiès M, Pouget J-P The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest. Leukemia. 2020;34(5):1315-1328. doi:10.1038/s41375-019-0677-4
Bastid J, Dejou C, Docquier A, Bonnefoy N The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.00718
Chabab G, Barjon C, Bonnefoy N, Lafont V Pro-tumor ?? T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.02186
Chabab G, Bonnefoy N, Lafont V IL-21 Signaling in the Tumor Microenvironment. Adv. Exp. Med. Biol.. 2020;1240. doi:10.1007/978-3-030-38315-2_6
Chabab G, Barjon C, Abdellaoui N, Salvador-Prince L, Dejou C, Michaud H-A, Boissière-Michot F, Lopez-Crapez E, Jacot W, Pourquier D, Bonnefoy N, Lafont V Identification of a regulatory V?1 gamma delta T cell subpopulation expressing CD73 in human breast cancer. J. Leukoc. Biol.. 2020;107(6):1057-1067. doi:10.1002/JLB.3MA0420-278RR
Bourillon L, Demontoy S, Lenglet A, Zampieri A, Fraisse J, Jarlier M, Boissière-Michot F, Perrochia H, Rathat G, Garambois V, Bonnefoy N, Michaud H-A, Chardès T, Tosi D, Pèlegrin A, Azria D, Larbouret C, Bourgier C Higher Anti-Tumor Efficacy of the Dual HER3-EGFR Antibody MEHD7945a Combined with Ionizing Irradiation in Cervical Cancer Cells. Int. J. Radiat. Oncol. Biol. Phys.. 2020;106(5):1039-1051. doi:10.1016/j.ijrobp.2019.12.020
Aroua N, Boet E, Ghisi M, Nicolau-Travers M-L, Saland E, Gwilliam R, de Toni F, Hosseini M, Mouchel P-L, Farge T, Bosc C, Stuani L, Sabatier M, Mazed F, Jarrou L, Gandarillas S, Bardotti M, Picard M, Syrykh C, Laurent C, Gotanegre M, Bonnefoy N, Bellvert F, Portais J-C, Nicot N, Azuaje F, Kaoma T, Joffre C, Tamburini J, Sarry J-E Extracellular ATP and CD39 activate cAMP-mediated mitochondrial stress response to promote cytarabine resistance in acute myeloid leukemia. Cancer Discov. Jul 08, 2020. doi:10.1158/2159-8290.CD-19-1008
Chabab G, Boissière-Michot F, Mollevi C, Ramos J, Lopez-Crapez E, Colombo P-E, Jacot W, Bonnefoy N, Lafont V Diversity of Tumor-Infiltrating, ?? T-Cell Abundance in Solid Cancers. Cells. 2020;9(6). doi:10.3390/cells9061537
Bonnefoy N, Olive D, Vanhove B [Next generation of anti-immune checkpoints antibodies]. Med Sci (Paris). 2019;35(12):966-974. doi:10.1051/medsci/2019193
Deligne C, Gros L [Anti-tumor monoclonal antibodies: new insights to elicit a long-term immune response]. Med Sci (Paris). 2019;35(12):982-989. doi:10.1051/medsci/2019194
Prunaretty J, Boisselier P, Riou O, Simeon S, Bedos L, Azria D, Fenoglietto P Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison. Rep Pract Oncol Radiother. 2019;24(1):97-104. doi:10.1016/j.rpor.2018.11.003
Andrade A, Tosi D, Michaud H-A, Coquel F, Desigaud D, Jarlier M, Coquelle A, Pasero P, Bonnefoy N, Martineau P, Del Rio M, Beijersbergen R, Vezzio-Vie N Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (ATR) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer. Cancer Res.. 2019;79(11):2933-2946. doi:10.1158/0008-5472.CAN-18-2807
Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz L, Roger P, Guiu S, Derocq D, Robin G, Michaud H-A, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget J-P, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. J Immunother Cancer. 2019;7(1):29. doi:10.1186/s40425-019-0498-z
Perrot I, Michaud H-A, Giraudon-Paoli M, Augier S, Docquier A, Gros L, Courtois R, Jecko D, Becquart O, Rispaud-Blanc H, Gauthier L, Rossi B, Chanteux S, Gourdin N, Amigues B, Roussel A, Bensussan A, Eliaou J-F, Bastid J, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E, Paturel C, Bonnefoy N Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies. Cell Rep. 2019;27(8):2411-2425.e9. doi:10.1016/j.celrep.2019.04.091
Groeneveld S, Faget J, Zangger N, Meylan E Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells. Oncotarget. 2018;9(64):32331-32345. doi:10.18632/oncotarget.25965
Institut de Recherche en Cancérologie de
